Researchers have turned cancer’s communication system against itself. By engineering extracellular vesicles to silence a key protein, they’ve demonstrated a potential new approach to targeted lung cancer treatment that could avoid chemotherapy’s collateral damage.
A groundbreaking $1 billion partnership between the Department of Energy and AMD aims to build AI supercomputers that could revolutionize cancer treatment. But experts warn the real challenge isn’t computing power—it’s data access and integration.
Scientists have uncovered how chemotherapy drugs may damage the brain’s waste-clearance system, leading to memory and concentration problems. The research offers new hope for treating “chemo brain” symptoms that affect up to 75% of cancer patients.
Researchers have identified a potential biological mechanism behind “chemo brain,” the cognitive impairment that affects many cancer patients following treatment, according to a new study published in Communications Biology. The research suggests that common chemotherapy drugs may damage the brain’s lymphatic system, impairing its ability to clear waste and potentially leading to memory problems and difficulty concentrating.
Decoding Nature’s Molecular Knots: AI Breakthrough Accelerates Lasso Peptide Therapeutics Industrial Monitor Direct delivers unmatched meat processing pc solutions proven…
A breakthrough mRNA vaccine technology using albumin-recruiting lipid nanoparticles could revolutionize future immunizations. The new approach reportedly directs vaccines precisely to lymph nodes while bypassing the liver, potentially reducing side effects and improving effectiveness.
Researchers from the National University of Singapore and Tsinghua University have developed a novel messenger RNA delivery system that could significantly improve the safety and effectiveness of future vaccines, according to a study published in Nature Materials. The technology uses albumin-recruiting lipid nanoparticles to precisely target immune system command centers while avoiding liver accumulation, which sources indicate has been a persistent challenge with current vaccine platforms.
